Anavex Life Sciences Stock (NASDAQ: AVXL) stock price, news, charts, stock research, profile.
Open | $5.53 |
Close | - |
Volume / Avg. | 178.74K / 1.06M |
Day Range | $5.40 - $5.63 |
52 Wk Range | 3.25 - 10.45 |
Market Cap | $478.19M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 23.59% |
Days to Cover | 33.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.
Other companies in Anavex Life Sciences’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR) and Altimmune (NASDAQ:ALT).
Anavex Life Sciences has a consensus price target of $33.00.
The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $5.6393 last updated September 24, 2024 at 1:50 PM EDT.
There are no upcoming dividends for Anavex Life Sciences.
Anavex Life Sciences’s Q4 earnings are confirmed for Monday, November 25, 2024.
There is no upcoming split for Anavex Life Sciences.
Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.